IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Aug 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-08-14

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-14	Common Stock	M	25000	$62	Acquired	835467	Direct
2020-08-14	Common Stock	S	6300	$377.93	Disposed	829167	Direct
2020-08-14	Common Stock	S	14423	$379.2561	Disposed	814744	Direct
2020-08-14	Common Stock	S	1816	$380.2589	Disposed	812928	Direct
2020-08-14	Common Stock	S	1877	$381.5329	Disposed	811051	Direct
2020-08-14	Common Stock	S	128	$382.6748	Disposed	810923	Direct
2020-02-14	Common Stock	S	200	$383.4420	Disposed	810723	Direct
2020-08-14	Common Stock	S	256	$384.1921	Disposed	810467	Direct
2020-08-17	Common Stock	M	19940	$62	Acquired	830407	Direct
2020-08-17	Common Stock	S	11857	$382.8546	Disposed	818550	Direct
2020-08-17	Common Stock	S	5704	$383.6633	Disposed	812847	Direct
2020-08-17	Common Stock	S	2379	$384.4809	Disposed	810467	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-14	Non-Qualified Stock Option (right-to-buy)	$62	M	25000	Disposed	2024-02-13	Common Stock (25000)	Direct
2020-08-17	Non-Qualified Stock Option (right-to-buy)	$62	M	19940	Disposed	2024-02-13	Common Stock (19940)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: Represents the weighted average price of the shares sold ranging from a low of $377.49 to a high of $378.43 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F2: Represents the weighted average price of the shares sold ranging from a low of $377.49 to a high of $378.43 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Represents the weighted average price of the shares sold ranging from a low of $379.87 to a high of $380.66 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F4: Represents the weighted average price of the shares sold ranging from a low of $381.29 to a high of $381.845 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F5: Represents the weighted average price of the shares sold ranging from a low of $382.51 to a high of $382.721 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F6: Represents the weighted average price of the shares sold ranging from a low of $383.247 to a high of $383.637 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F7: Represents the weighted average price of the shares sold ranging from a low of $384.075 to a high of $384.225 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F8: Represents the weighted average price of the shares sold ranging from a low of $382.099 to a high of $383.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F9: Represents the weighted average price of the shares sold ranging from a low of $383.129 to a high of $384.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F10: Represents the weighted average price of the shares sold ranging from a low of $384.28 to a high of $385.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F11: Grant of option to buy 44,535 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2015 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F12: Not applicable.